Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial
大麻二酚能否减轻精神分裂症患者使用大麻的不良反应?一项随机、双盲、交叉试验
期刊:Neuropsychopharmacology
影响因子:7.1
doi:10.1038/s41386-025-02175-3
Chesney, Edward; Oliver, Dominic; Sarma, Ananya; Lamper, Ayşe Doğa; Slimani, Ikram; Lloyd, Millie; Dickens, Alex M; Welds, Michael; Kråkström, Matilda; Gasparini-Andre, Irma; Orešič, Matej; Lawn, Will; Babayeva, Natavan; Freeman, Tom P; Englund, Amir; Strang, John; McGuire, Philip